The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A stock sharply lower in recent months For AstraZeneca alone, the molecule generated revenue of $1.8bn in 2025, giving it blockbuster status (blockbuster). Experts at the European Medicines Agency ...
(Alliance News) - AstraZeneca PLC on Wednesday said the EU approved Trixeo Aerosphere for the maintenance treatment of asthma. The Cambridge, England-based pharmaceutical maker said the approval by ...
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. AstraZeneca has received European Union approval for Imfinzi in combination with FLOT ...
AstraZeneca ( AZN ), a biopharmaceutical company, said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Enhertu for an additional early ...
Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its antibody-drug conjugate Dato-DXd marketed ...
AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) announced Tuesday they have withdrawn the EU marketing application for their experimental lung cancer therapy, datopotamab deruxtecan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results